Gastrointestinal Surgery of Neuroendocrine Neoplasms

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Gastrointestinal Surgery of Neuroendocrine Neoplasms. / Hansen, Carsten Palnæs; Olsen, Ingrid Marie Holst; Knigge, Ulrich.

Neuroendocrine Tumors: A Multidisciplinary Approach. Vol. 44 2015. p. 149-63 (Frontiers of Hormone Research).

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Hansen, CP, Olsen, IMH & Knigge, U 2015, Gastrointestinal Surgery of Neuroendocrine Neoplasms. in Neuroendocrine Tumors: A Multidisciplinary Approach. vol. 44, Frontiers of Hormone Research, pp. 149-63. https://doi.org/10.1159/000382144

APA

Hansen, C. P., Olsen, I. M. H., & Knigge, U. (2015). Gastrointestinal Surgery of Neuroendocrine Neoplasms. In Neuroendocrine Tumors: A Multidisciplinary Approach (Vol. 44, pp. 149-63). Frontiers of Hormone Research https://doi.org/10.1159/000382144

Vancouver

Hansen CP, Olsen IMH, Knigge U. Gastrointestinal Surgery of Neuroendocrine Neoplasms. In Neuroendocrine Tumors: A Multidisciplinary Approach. Vol. 44. 2015. p. 149-63. (Frontiers of Hormone Research). https://doi.org/10.1159/000382144

Author

Hansen, Carsten Palnæs ; Olsen, Ingrid Marie Holst ; Knigge, Ulrich. / Gastrointestinal Surgery of Neuroendocrine Neoplasms. Neuroendocrine Tumors: A Multidisciplinary Approach. Vol. 44 2015. pp. 149-63 (Frontiers of Hormone Research).

Bibtex

@inbook{5bcdcb183c1b48c795f48f975fd60cf7,
title = "Gastrointestinal Surgery of Neuroendocrine Neoplasms",
abstract = "Surgery is the only treatment that may cure the patient with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) and should always be considered as the first-line treatment if radical resection can be achieved. Even in cases where radical surgery is not possible, palliative resection may be performed to reduce local or hormone-induced symptoms and to improve quality of life. The surgical procedures for GEP-NENs are accordingly described below. In most patients life-long follow-up is required, even following radical surgery, as recurrence may occur several years later.",
author = "Hansen, {Carsten Paln{\ae}s} and Olsen, {Ingrid Marie Holst} and Ulrich Knigge",
note = "{\textcopyright} 2015 S. Karger AG, Basel.",
year = "2015",
doi = "10.1159/000382144",
language = "English",
isbn = "978-3-318-02772-3",
volume = "44",
series = "Frontiers of Hormone Research",
publisher = "S Karger AG",
pages = "149--63",
booktitle = "Neuroendocrine Tumors",

}

RIS

TY - CHAP

T1 - Gastrointestinal Surgery of Neuroendocrine Neoplasms

AU - Hansen, Carsten Palnæs

AU - Olsen, Ingrid Marie Holst

AU - Knigge, Ulrich

N1 - © 2015 S. Karger AG, Basel.

PY - 2015

Y1 - 2015

N2 - Surgery is the only treatment that may cure the patient with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) and should always be considered as the first-line treatment if radical resection can be achieved. Even in cases where radical surgery is not possible, palliative resection may be performed to reduce local or hormone-induced symptoms and to improve quality of life. The surgical procedures for GEP-NENs are accordingly described below. In most patients life-long follow-up is required, even following radical surgery, as recurrence may occur several years later.

AB - Surgery is the only treatment that may cure the patient with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) and should always be considered as the first-line treatment if radical resection can be achieved. Even in cases where radical surgery is not possible, palliative resection may be performed to reduce local or hormone-induced symptoms and to improve quality of life. The surgical procedures for GEP-NENs are accordingly described below. In most patients life-long follow-up is required, even following radical surgery, as recurrence may occur several years later.

U2 - 10.1159/000382144

DO - 10.1159/000382144

M3 - Book chapter

C2 - 26303710

SN - 978-3-318-02772-3

VL - 44

T3 - Frontiers of Hormone Research

SP - 149

EP - 163

BT - Neuroendocrine Tumors

ER -

ID: 162611030